about
The human gut microbiota and virome: Potential therapeutic implicationsPNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies.Management of refractory typical GERD symptoms.Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.Gallstones in cystic fibrosis: a critical reappraisal.An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease.Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C.The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy.A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B.Sterile abscesses complicating monoclonal gammopathy of undetermined significance.Patterns of chronic hepatitis B in Central Italy: a cross-sectional study.Incidence and natural history of small esophageal varices in cirrhotic patients.Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: a retrospective case-control study.Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone formation?Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.HAMP gene mutation c.208T>C (p.C70R) identified in an Italian patient with severe hereditary hemochromatosis.Gallstones and diabetes: a case-control study in a free-living population sample.Biliary secretion of phosphatidylcholine and its molecular species in cholecystectomized T-tube patients: effects of bile acid hydrophilicity.Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results.Activation of the IGF1 System Characterizes Cholangiocyte Survival During Progression of Primary Biliary CirrhosisAbnormalities in erythrocyte membrane phospholipids in patients with liver cirrhosisEvaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosisHepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factorsCost analysis for the prevention of variceal rebleeding: A comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of italian cirrhotic patientsUltrasonography in the study of hepatocellular carcinoma in woodchucks chronically infected with WHVA two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumptionBeta adrenergic receptors in the parathyroid glandsProbiotics for the hemodynamic alterations of patients with liver cirrhosisEstrogen receptors in cholangiocytes and the progression of primary biliary cirrhosisSystemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot studyHepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imagingLong-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis
P50
Q28266057-FB807377-30BC-45F8-A55D-36132C35424BQ34693476-F8C93644-2EF9-4685-A6C4-8D196C53F8D8Q37706062-4C8BEBFB-8533-4B82-B34D-01E35D27163CQ38807565-ABA33BE7-68E5-41C8-9A66-0164DE4AFEB1Q40528517-407D85CC-63F7-4F2A-9047-D820F48BC2CFQ41169611-C95E78D6-5C96-4BD5-AE24-72669BBDE3A2Q42274607-FD267F47-2085-492A-A61F-47CAEDAAA58DQ42978719-9B93AEB8-7DAE-4DCC-A9AA-0985E0A7AC81Q43040151-A2B89028-B144-4AEA-A725-490B7C482727Q43208914-A1F68563-D437-4AB0-A338-04CD860AD134Q43624601-99A06485-9543-4519-AF83-8150BDE3902AQ44207665-47DAE149-0135-4B53-AFA7-571D79975BC5Q44370094-C747235C-F17F-4AA1-892B-984E97FB70CDQ44693272-86754824-D262-4665-9C73-0870AF418B9BQ45173915-0E06480D-5A56-4E37-B108-B839AF86B37BQ46385914-09E7B273-4191-4A98-97B2-364BD20F1683Q47942288-3CB905F0-1F59-431B-901D-AC12B9D89F54Q50157670-1887DEAD-74AA-49B2-AE7D-3DA43EC1CC59Q50178581-7F898D36-5F13-4BD9-A3F4-010581A512CBQ51697841-5481BC54-A6DB-4F4E-8008-B97F0BFDFCABQ57791888-32897590-04DF-436E-8D20-B39E3DAFAC8CQ57792322-D3776A3E-98B1-4E04-A3A0-32A29D2694BBQ58421116-DD751189-F542-4324-B186-A7C685C446A0Q60198862-3DBFFE2A-1EF5-45D2-AE8E-54B49FC7F406Q60199011-5BE3FF82-896F-4D51-974B-E20BF48EE462Q60331174-B20BD493-89F6-47DF-B652-8E1413DD8D79Q60912314-315D3EC6-B5C3-48EA-B13F-2D4266E1DBAFQ72869752-A90EC3A2-5E7A-4637-9819-5A49F5472978Q73363189-BCA788DF-A570-40B7-A998-78DBADBBF83FQ81258801-6D93343D-2517-4502-94DE-5565A5616846Q84698353-B2A07170-CDF1-4E69-8C1E-7D067E09808AQ85523963-A0560A0B-0CBD-471A-A1D1-7A30588C1557Q91253680-0C042293-4E5B-4B11-8963-323798416F9B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Adriano De Santis
@en
Adriano De Santis
@es
De Santis A
@nl
De Santis A
@sl
type
label
Adriano De Santis
@en
Adriano De Santis
@es
De Santis A
@nl
De Santis A
@sl
altLabel
De Santis A
@en
prefLabel
Adriano De Santis
@en
Adriano De Santis
@es
De Santis A
@nl
De Santis A
@sl
P1053
M-9712-2013
P106
P1153
8644317200
P21
P31
P3829
P496
0000-0001-7338-9203